Ghatkopar (East), Mumbai)
Home > General Medicines > COPD Treatment
COPD Treatment in Mumbai
Managing Breathlessness, Protecting Lung Function, and Reducing Exacerbations
Chronic Obstructive Pulmonary Disease is a progressive lung condition - but progression is not inevitable when the right management is in place from the right time. COPD treatment in Mumbai at Shree Hospitals provides comprehensive chronic obstructive pulmonary disease management for breathlessness and exacerbations through an experienced pulmonology team.
From spirometry-confirmed diagnosis and inhaler therapy optimisation to structured bronchodilator and pulmonary rehabilitation for COPD patients, our programme is built around maximising lung function, minimising exacerbation frequency, and improving the daily quality of life of every patient living with this challenging condition.
Having Trouble Breathing? Get Immediate Respiratory Care in Mumbai.
Quick facts
Condition: Progressive obstructive lung disease - irreversible airflow limitation
Diagnosis: Post-bronchodilator spirometry - FEV1/FVC below 0.70 confirms COPD
GOLD Staging: GOLD 1 to 4 based on FEV1 percentage predicted
Treatment: SABA, LABA, LAMA, ICS/LABA combinations, and roflumilast
Exacerbation Management: Systemic steroids, antibiotics, nebulization, and oxygen
Rehabilitation: Pulmonary rehabilitation - exercise, education, and breathing techniques
Goal: Reduce symptoms, prevent exacerbations, and slow functional decline
What is COPD Treatment?
Chronic Obstructive Pulmonary Disease is a preventable and treatable lung disease characterised by persistent respiratory symptoms and irreversible airflow limitation caused by airway and alveolar damage - most commonly from long-term tobacco smoke exposure, though occupational dust, biomass fuel smoke, and recurrent childhood respiratory infections also contribute significantly in the Indian context.
Chronic obstructive pulmonary disease management for breathlessness and exacerbations at Shree Hospitals begins with spirometry-confirmed diagnosis - a post-bronchodilator FEV1/FVC ratio below 0.70 is the diagnostic standard - followed by GOLD severity staging, assessment of symptom burden using the CAT or mMRC dyspnoea scale, and exacerbation history to determine which ABCD treatment group the patient belongs to. COPD inhaler therapy is the foundation of management - short-acting bronchodilators for symptom relief, and long-acting bronchodilators (LABA, LAMA, or combined LABA/LAMA) as maintenance therapy.
Inhaled corticosteroid-containing combinations are added for patients with frequent exacerbations and blood eosinophilia. COPD exacerbation management - acute worsening of respiratory symptoms requiring treatment change - is managed with systemic corticosteroids, antibiotics for infective exacerbations, nebulized bronchodilators, oxygen therapy, and if necessary non-invasive ventilation.
Bronchodilator and pulmonary rehabilitation for COPD patients through a structured exercise, education, and breathing technique programme significantly improves exercise capacity, dyspnoea, and quality of life - with evidence of benefit exceeding any pharmacological intervention currently available for COPD.
When Should COPD Be Suspected and Investigated?
- Persistent breathlessness on exertion in a current or ex-smoker above 40 years
- Chronic productive cough lasting more than 3 months in 2 consecutive years
- Recurrent chest infections requiring antibiotics - particularly in winter months
- Wheeze and chest tightness not responding adequately to bronchodilator therapy
- Significant occupational or biomass smoke exposure with unexplained breathlessness
How is COPD Severity Assessed?
- Spirometry diagnosis - post-bronchodilator FEV1/FVC below 0.70 confirms airflow obstruction
- FEV1 percentage predicted determines GOLD severity grade 1 to 4
- CAT questionnaire - 8-item symptom assessment tool quantifying COPD impact on daily life
- mMRC dyspnoea scale - 0 to 4 grading of breathlessness at different activity levels
- Exacerbation history - number of exacerbations in the previous year determines treatment group
Why COPD is Undertreated and Underdiagnosed in India?
- Many patients attribute breathlessness to ageing or deconditioning and do not seek medical assessment
- Spirometry is underused outside specialist settings - clinical diagnosis misses the severity of airflow limitation
- COPD inhaler therapy is frequently prescribed at inadequate doses or with incorrect inhaler technique
- Smoking cessation - the only intervention proven to slow FEV1 decline - is rarely systematically addressed
- Pulmonary rehabilitation remains severely underutilised despite evidence of greater benefit than any drug
COPD treatment helps improve breathing, reduce flare-ups, and enhance overall lung function and quality of life.
Patients receiving comprehensive COPD care often experience better symptom control, increased activity levels, and fewer hospital visits.
24×7 Emergency Care
Our Approach to COPD Treatment
At Shree Hospitals, COPD treatment in Mumbai follows current GOLD guideline recommendations - with every patient assessed using spirometry, symptom questionnaires, and exacerbation history before any treatment decision is made.
Our pulmonology team selects the most appropriate inhaler combination for each patient's GOLD group - and addresses smoking cessation, inhaler technique, vaccination, and rehabilitation as essential components of every COPD management plan.
24×7 Emergency Care
Spirometry-Based Diagnosis and GOLD Staging
Every patient with suspected COPD undergoes post-bronchodilator spirometry in our pulmonary function laboratory. FEV1, FVC, FEV1/FVC ratio, and flow-volume loop morphology are reviewed by the pulmonologist. Spirometry diagnosis confirms airflow limitation, quantifies severity, and distinguishes COPD from asthma - critical for selecting the correct treatment pathway from the outset.
Inhaler Therapy Optimisation
Inhaler choice and technique are optimised at every appointment. Short-acting bronchodilators (salbutamol, ipratropium) are prescribed for rescue use. Long-acting LAMA therapy - tiotropium or umeclidinium - is the preferred maintenance treatment for GOLD B and C patients. LABA/LAMA combinations are used for patients with persistent dyspnoea. ICS is added only for patients with frequent exacerbations and elevated blood eosinophil count.
Exacerbation Prevention and Management
COPD exacerbation management prevention includes vaccination - annual influenza and pneumococcal - optimised maintenance inhaler therapy, and early patient education on recognising and responding to exacerbations. When exacerbations occur, systemic prednisolone for 5 days, antibiotics for infective episodes, and intensified nebulized bronchodilator therapy are initiated promptly to minimise hospitalisation duration and prevent FEV1 decline.
Pulmonary Rehabilitation Programme
Our structured pulmonary rehabilitation programme consists of 8 to 12 weeks of supervised exercise training, breathing retraining, energy conservation techniques, and nutritional guidance - delivered by physiotherapists and respiratory nurses with COPD specialist training. Rehabilitation significantly improves exercise capacity, dyspnoea, and quality of life - with effects maintained for 12 to 18 months post-programme in compliant patients.
Pulmonologist (Chest Physician) in Mumbai
Book Expert Consultation
Dr. Pratik Bhupendra Gopani
Consulting Physician – Internal Medicine
Pulmonology and Respiratory Services at Shree Hospitals
COPD management at Shree Hospitals is embedded within a comprehensive respiratory medicine programme - providing spirometry, advanced imaging, nebulization, non-invasive ventilation, pulmonary rehabilitation, and specialist outpatient care for the full range of chronic and acute respiratory conditions.
Spirometry and Pulmonary Function Testing
Post-bronchodilator spirometry, lung volumes, and diffusing capacity measurement for COPD diagnosis, severity assessment, and treatment response monitoring.
Nebulization Therapy
Emergency and scheduled bronchodilator nebulization for COPD exacerbations and patients unable to use dry powder or pressurised inhalers effectively.
Non-Invasive Ventilation (NIV)
BiPAP non-invasive ventilation for acute hypercapnic respiratory failure during severe COPD exacerbations - avoiding intubation in eligible patients.
Respiratory Infection Treatment
Antibiotic therapy and supportive management for infective COPD exacerbations - the most common precipitant of acute deterioration.
Chest Physiotherapy
Airway clearance techniques, huff coughing, and active cycle of breathing for patients with excessive sputum production and mucus retention.
Step by Step Process of COPD Treatment
- Initial Respiratory Assessment and Spirometry
The patient's respiratory history - symptom onset, breathlessness grade, cough, sputum, exacerbation frequency, smoking history, and occupational exposure - is documented in detail. Post-bronchodilator spirometry is performed. Spirometry diagnosis confirming FEV1/FVC below 0.70 establishes the COPD diagnosis. Chest X-ray and arterial blood gas are obtained where indicated.
- GOLD Staging and ABCD Group Classification
FEV1 percentage predicted determines the GOLD severity grade 1 to 4. CAT score and mMRC dyspnoea scale classify symptom burden. Exacerbation history in the preceding 12 months determines ABCD treatment group - which drives initial pharmacological treatment selection as per current GOLD guidelines.
- Inhaler Prescription, Device Selection, and Technique Training
The most appropriate maintenance inhaler - LAMA, LABA/LAMA, or ICS/LABA/LAMA - is selected for the patient's ABCD group. The inhaler device most compatible with the patient's inspiratory flow, hand strength, and cognitive ability is chosen. Inhaler technique is demonstrated and the patient performs observed technique before leaving the clinic - because incorrect technique is the most common cause of apparent treatment failure.
- Smoking Cessation, Vaccination, and Lifestyle Modification
Smoking cessation counselling and pharmacotherapy - varenicline, bupropion, or nicotine replacement - are offered at every appointment for current smokers. Annual influenza vaccine and pneumococcal vaccine are administered. Nutritional assessment addresses undernutrition - a common and clinically significant problem in moderate to severe COPD.
- Exacerbation Action Plan and Emergency Guidance
Every patient receives a written COPD action plan covering early recognition of exacerbation symptoms, when to start rescue oral prednisolone and antibiotics, when to attend emergency, and when to call an ambulance. COPD exacerbation management initiated within 24 hours of symptom onset significantly reduces exacerbation severity and hospitalisation rate.
- Pulmonary Rehabilitation Referral and Long-Term Follow-Up
All patients with mMRC dyspnoea grade 2 or above are referred to the pulmonary rehabilitation programme. Spirometry is repeated annually to monitor FEV1 decline rate. Inhaler technique and adherence are reviewed at every 3 to 6 monthly appointment. Blood eosinophil count is checked annually to guide ICS addition or removal from the inhaler regimen.
Patient Questions About COPD Treatment
What are the benefits of structured COPD management?
Structured COPD management helps reduce breathlessness, prevent flare-ups, improve lung function, increase exercise capacity, and enhance quality of life through the right medications, pulmonary rehabilitation, and lifestyle changes.
What are the side effects of COPD medications?
COPD medications are generally safe, but some may cause dry mouth, tremors, palpitations, hoarseness, oral thrush, or stomach upset. Your doctor will monitor treatment and adjust medications if needed.
What should patients ask the pulmonologist?
Patients should ask about their COPD stage, the most suitable inhaler, correct inhaler technique, pulmonary rehabilitation, how to manage flare-ups, and ways to slow disease progression.
Beyond Inhalers - Full Respiratory Programme at Shree Hospitals
Shree Hospitals offers comprehensive COPD care including pulmonary rehabilitation, home oxygen assessment, smoking cessation support, respiratory infection treatment, sleep studies, and advanced therapies for severe lung disease.
Patient
Resources
Schedule
consultation
Billing &
Payments
Hospital
Facilities
24×7 Emergency Care
1800-268-4000
Follow Us
Shree
Hospitals
Shree
Hospitals
